BNR Shariah Compliance
Screening Methodology: AAOIFI
NOT HALAL
Last Updated: March 27, 2026
Report Source: 2025 Annual Report
Burning Rock Biotech Ltd. Stock Analysis BNR
Burning Rock Biotech Ltd. engages in the investment of medical fields. The firm operates three businesses, including central laboratory business, in-hospital business and pharma research and development services. Central laboratory business mainly includes the sales of its cancer therapy selection test to individual patient customers. In-hospital business includes the manufacture and sales of reagent kits, as well as the provision of facilitation services for laboratory equipment sold to hospitals. The pharma research and development services include a range of cancer therapy selection test services, analytical validation services and project management services.
Read More Burning Rock Biotech Ltd (BNR) Chart
Key Statistics of Burning Rock Biotech Ltd (BNR)
Key statistics in the stock market are essential financial indicators that measure a company's performance, valuation, profitability, and risk.
Today's Range
Today's Open
$17.58Volume
43.56KP/E Ratio (TTM)
-52 Week Range
Market Cap
180.81MAvg. Volume
23.00KDividend Yield
-Financial Metrics & Statements of Burning Rock Biotech Ltd (BNR)
FAQ's for Burning Rock Biotech Ltd (BNR)
- According to Musaffa’s Shariah screening methodology, Burning Rock Biotech Ltd (BNR) is currently classified as NOT HALAL as of March 2026. The classification is based on an evaluation of the company’s business activities and financial ratios to determine whether it meets Islamic investment guidelines.